Zobrazeno 1 - 10
of 341
pro vyhledávání: '"donor deferral"'
Autor:
Akshaya Tomar, Amit Kumar Biswas, Amit Pawar, Ujjwal Dimri, Deepak Kumar, Ajay Kumar Baranwal
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 4, Pp 456-460 (2023)
Introduction: Approximately 55.52% of the Indian population had been fully vaccinated by Jan. 2022, since its first roll out on January 16, 2021. A few concerns were raised concerning the Covishield vaccination related to thrombotic thrombocytopenia.
Externí odkaz:
https://doaj.org/article/dac39bdcc10941ceb01db2e57a6f0aa0
Autor:
Wang Feng, Wang Yun, Wang Le, Xu Zhi-guo, Yang Hai-ying, Wu Shu-fang, Wei Zhen-yan, Chen Yi-zhu, Sun Quan, Fei Jing-xian
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectiveThis study analysed blood donation deferral trends, reasons and demographic/lifestyle characteristics among students in Huzhou City. The aim was to understand the health status of students and reduce the deferral rate.MethodsData on blood do
Externí odkaz:
https://doaj.org/article/2e7d7a2b32c14b3bbf65de0abad1d51e
Autor:
Sheetal Malhotra, Gita Negi
Publikováno v:
Asian Journal of Transfusion Science, Vol 17, Iss 1, Pp 48-52 (2023)
INTRODUCTION: Safe blood donors form the backbone of safe blood transfusion services.[1] Donor eligibility policies are a critical layer of blood safety designed to ensure selection of healthy donors and to protect recipients from any harm. This stud
Externí odkaz:
https://doaj.org/article/dc3f2fd377de4f8d980d21f07c4ea869
Publikováno v:
Zhongguo shuxue zazhi, Vol 35, Iss 12, Pp 1212-1216 (2022)
Objective To establish deferral criterion of HIV ELISA (enzyme-linked immunosorbent assay) and electrochemiluminescence immunoassay(ECLIA) by using receiver operating characteristic curve(ROC) method to screen HIV reactive blood donors suitable for e
Externí odkaz:
https://doaj.org/article/86391a96a2174e618d44db85e9025001
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 73, Iss 5 (2023)
Objective: To reassess the reasons for blood donor deferrals as per donor history questionnaire and physical examination findings. Study Design: Cross-sectional study. Place and Duration of Study: Blood Bank, Dr. Ziauddin Hospital, Karachi Pakist
Externí odkaz:
https://doaj.org/article/42ac0b458cc34f23a755bc05bb90c5bc
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S42- (2023)
Backround: Enhancing blood safety and donor eligibility are vital in blood banking. We analyze our blood center's approach and Turkey's general strategy in this domain, focusing on identifying and mitigating the reasons for donor deferral. Materials
Externí odkaz:
https://doaj.org/article/f8aeb02802344870878de677c4752550
Autor:
Jaffe, Harold W., author
Publikováno v:
Dispatches from the AIDS Pandemic : A Public Health Story, 2023, ill.
Externí odkaz:
https://doi.org/10.1093/oso/9780197626528.003.0008
Publikováno v:
Zhongguo shuxue zazhi, Vol 35, Iss 2, Pp 176-179 (2022)
Objective To discuss the reliability and applicability of the current blood deferral strategy concerning anti-TPreactive blood donors (by ELISA). Methods TPPA confirmatory test was performed on the samples routinely detected by two different anti-TP
Externí odkaz:
https://doaj.org/article/5f53eb334df94dafb5bb3168068c1eda
Publikováno v:
Iraqi Journal of Hematology, Vol 11, Iss 2, Pp 145-150 (2022)
BACKGROUND: Amidst the raging coronavirus disease-2019 (COVID-19 pandemic), COVID-19 convalescent plasma (CCP) therapy emerged as an important experimental therapy. The majority of the research studies have focused on determining the safety and effic
Externí odkaz:
https://doaj.org/article/4b2c5eeac1254da9a4b629ed3a3017f4
Publikováno v:
Asian Journal of Transfusion Science, Vol 16, Iss 2, Pp 214-218 (2022)
BACKGROUND: Increasing demand of single donor platelet requires blood banks to expand the donor pool. A reassessment of donor deferral criteria for plateletpheresis is required to ensure that this increasing demand is met without compromising on prod
Externí odkaz:
https://doaj.org/article/92899a90cd184bcc957223423e0429e7